ODI Pharma AB (ODI.ST)
ODI Pharma AB operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Stockholm, AB, SE. The stock last traded at $1.95, up 0.00% on the session, giving a market capitalisation of $35.7M. Its beta of 0.79 implies it has historically moved less than the broad market.
Based in Stockholm, Sweden, ODI Pharma AB (publ) is a pharmaceutical enterprise that commenced operations in 2018. This company specializes in the manufacture and supply of both medicinal cannabis and cosmetic items throughout Europe. Its product line includes cannabidiol-enriched skincare solutions, such as facial creams, masks, and body balms, all sold under the Kandol. brand via its e-commerce site, kandol.net.
ODI Pharma AB is most often compared with the following Healthcare names: